Literature DB >> 11472471

Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.

I S Ismail1, W Nazaimoon, W Mohamad, R Letchuman, M Singaraveloo, F L Hew, C Shuguna, B A Khalid.   

Abstract

AIMS: To define the prevalence of dyslipidaemia in young diabetic patients in Peninsular Malaysia and the contributory factors of dyslipidaemia in these subjects.
METHODS: This is a cross-sectional study involving 848 young diabetic patients from seven different centres, with representation from the three main ethnic groups. Clinical history and physical examination was done and blood taken for HbA1c, fasting glucose, total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and triglycerides.
RESULTS: The overall lipids were suboptimal, worse in Type 2 diabetes mellitus (DM) patients compared with Type 1 DM patients. Of the Type 2 patients, 73.2% had total cholesterol > 5.20 mmol/l, 90.9% had LDL-cholesterol > 2.60 mmol/l, 52.6% had HDL-cholesterol < 1.15 mmol/l and 27.3% had serum triglycerides > 2.30 mmol/l. There were ethnic differences in the lipid levels with the Malays having the highest total cholesterol (mean 6.19 mmol/l), and the highest LDL-cholesterol (mean 4.16 mmol/l), while the Chinese had the highest HDL-cholesterol (geometric mean 1.24 mmol/l). Ethnicity was an important determinant of total, LDL- and HDL-cholesterol in Type 2 DM, and LDL- and HDL-cholesterol and triglycerides in Type 1 DM. Glycaemic control was an important determinant of total, LDL-cholesterol and triglycerides in both Type 1 and Type 2 DM. Waist-hip ratio (WHR) was an important determinant of HDL-cholesterol and triglycerides in both types of DM. Gender was an important determinant of HDL-cholesterol in Type 2 DM, but not in Type 1 DM. Socioeconomic factors and diabetes care facilities did not have any effect on the dyslipidaemia.
CONCLUSIONS: The prevalence of dyslipidaemia was high especially in Type 2 DM patients. Ethnicity, glycaemic control, WHR, and gender were important determinants of dyslipidaemia in young diabetic patients. Diabet. Med. 18, 501-508 (2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472471     DOI: 10.1046/j.1464-5491.2001.00494.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Dyslipidaemic pattern of patients with type 2 diabetes mellitus.

Authors:  Eid Mohamed; Mafauzy Mohamed; Faridah Abdul Rashid
Journal:  Malays J Med Sci       Date:  2004-01

2.  Glycaemic control of type 2 diabetic patients on follow up at hospital universiti sains malaysia.

Authors:  M Eid; M Mafauzy; Ar Faridah
Journal:  Malays J Med Sci       Date:  2003-07

3.  Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia.

Authors:  Chun Wie Chong; Arine Fadzlun Ahmad; Yvonne Ai Lian Lim; Cindy Shuan Ju Teh; Ivan Kok Seng Yap; Soo Ching Lee; Yuee Teng Chin; P'ng Loke; Kek Heng Chua
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

Review 4.  Comorbidities, complications and mortality in people of South Asian ethnicity with type 1 diabetes compared with other ethnic groups: a systematic review.

Authors:  Komil N Sarwar; Phoebe Cliff; Ponnusamy Saravanan; Kamlesh Khunti; Krishnarajah Nirantharakumar; Parth Narendran
Journal:  BMJ Open       Date:  2017-07-13       Impact factor: 2.692

5.  Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.

Authors:  Mona Kamal Saadeldin; Shereen Saeid Elshaer; Ibrahim Ali Emara; Mohamad Maged; Amal Kamal Abdel-Aziz
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

6.  A pilot study: the development of a culturally tailored Malaysian Diabetes Education Module (MY-DEMO) based on the Health Belief Model.

Authors:  Badariah Ahmad; Amutha Ramadas; Quek Kia Fatt; Anuar Zaini Md Zain
Journal:  BMC Endocr Disord       Date:  2014-04-08       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.